Pagliuca, Simona http://orcid.org/0000-0003-4688-2478
Gurnari, Carmelo
Hercus, Colin
Hergalant, Sébastien http://orcid.org/0000-0001-8456-7992
Nadarajah, Niroshan
Wahida, Adam
Terkawi, Laila
Mori, Minako
Zhou, Weiyin
Visconte, Valeria http://orcid.org/0000-0002-2993-1509
Spellman, Stephen http://orcid.org/0000-0002-7271-8252
Gadalla, Shahinaz M.
Zhu, Caiying
Zhu, Ping http://orcid.org/0000-0002-4521-7524
Haferlach, Torsten http://orcid.org/0000-0003-0196-2837
Maciejewski, Jaroslaw P. http://orcid.org/0000-0002-6837-4346
Funding for this research was provided by:
Fondation ARC pour la Recherche sur le Cancer
Aplastic Anemia and MDS International Foundation
Association HPN France – Aplasie médullaire and Foundation For Rare Diseases (FFRD) Italian Society of Hematology Italian Society of Experimental Hematology
American-Italian Cancer Foundation
VeloSano Pilot Award Vera and Joseph Dresner Foundation–MDS
U.S. Department of Health & Human Services | U.S. Public Health Service
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | U.S. Public Health Service
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Edward P. Evans Foundation
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 9 July 2022
Revised: 25 September 2022
Accepted: 4 October 2022
First Online: 17 October 2022
Competing interests
: This research was conducted in absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Collaboration between Cleveland Clinic and Novocraft was based on a no-profit academic partnership.